-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… worse and survival. In contrast, Abraxane was more effective than conventional … metastatic adenocarcinoma of the pancreas, Abraxane was shown to improve overall … non-small cell lung cancer, 33% of patients receiving Abraxane and carboplatin responded …
-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
29 Jan 2025 12:00 GMT
… ) (a therapeutically equivalent product to Abraxane®) in the United States for … or metastatic non-small cell lung cancer, and the treatment of patients …
-
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
27 Jan 2025 14:00 GMT
… in treating liver metastases, lung cancer and rectal cancer - … after receiving second-line Gemcitabine-Abraxane chemotherapy (n=7), … of second-line Gemcitabine-Abraxane.
In today’s presentation … treatment delivered into a lung tumor, ten Alpha DaRT sources …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
FDA approves new Bristol Myers drug for lung cancer
16 Nov 2023 21:00 GMT
… Myers Squibb’s new lung cancer medication Augtyro, which the … with non-small cell lung cancer have this alteration, and … Opdivo transformed the treatment of lung cancer. But for patients with … lived products like Revlimid, Abraxane and Eliquis hit or approach …
-
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
27 Sep 2023 03:17 GMT
… SoC -
Small Cell Lung Cancer Program
- Preliminary data from … onvansertib with SoC (Gemzar + Abraxane). In cohort 2, patients … initiated trials in small cell lung cancer (SCLC) and triple … -cancer-and-small-cell-lung-cancer-including-single-agent-activity- …
-
IMM-1-104 Plus Chemo Generates Responses in First-Line Pancreatic Cancer
20 Jan 2025 20:16 GMT
… modified gemcitabine and nab-paclitaxel (Abraxane) led to responses and disease … RAS-mutant non–small cell lung cancer (NSCLC) to receive the agent …
-
IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer
18 Jan 2025 01:51 GMT
… with modified Gemzar plus Abraxane (gemcitabine plus nab-paclitaxel … with modified [Gemzar plus Abraxane] may provide improved … versus [Gemzar plus Abraxane alone] in the … lung cancer].”
The Phase 3 MPACT study established benchmarks for Gemzar plus Abraxane …
About
© 1995-2025